Sessa Capital GP, LLC - Insider Non-Derivative Transactions at SAB Biotherapeutics, Inc. (SABS) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Sep 29, 2025, Sessa Capital GP, LLC's relationship to SAB Biotherapeutics, Inc. (SABS) is Director, and currently has 2,198,457 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SABS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Sessa Capital GP, LLC - Insider Non-Derivative Transactions of SABS Common Stock

Sessa Capital GP, LLC - Insider Non-Derivative Transactions at SABS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Sep 30, 2025	M -- (Common Stock)	1740000	1.75	2198457